New APPS

Remdesivir has been one of the most closely watched potential therapies for COVID-19, and a couple of early cohort and observational studies have been encouraging.  But apparently the first results from a randomized controlled trial in China indicate that it did not make a statistically significant difference.  At least, it looks that way: results were accidentally posted on the WHO website and then removed, with a promise of an official publication to come later.  It's all a bit murky, and there's a number of other trials ongoing, but this is not the sort of result you hope to see, even accidentally.